ConductScience.org, home

Paper488922

Prognostic significance of the histological features of malignant melanoma.

McGovern VJ and 3 others. Histopathology, 1979. Cited by 165 papers, by iCite.

Cite this record

ConductScience Library. Prognostic significance of the histological features of malignant melanoma. Papers, record 488922. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/488922

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic significance of the histological features of malignant melanoma.
PubMed
Journal
Histopathology
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
165
iCite
Relative citation ratio, by iCite
7.1
iCite
Revised in PubMed
2019-08-19
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McGovern VJV J
2Shaw HMH M
3Milton GWG W
4Farago GAG A

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelanomaMajor topic
Humans
Neoplasm Staging
Prognosis

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 165 citations.

PMIDTitleJournalYearIn PapersSource
30381323Disparities in diagnosis of advanced melanoma: a population-based cohort study.CMAJ Open2018https://conductscience.org/library/papers/30381323PubMed
27502743Breslow density is a novel prognostic feature in cutaneous malignant melanoma.Histopathology2017https://conductscience.org/library/papers/27502743PubMed
23785613"Mitogenicity"-the latest and mosthilarious episode in the slapstick comedy of melanoma management.Dermatol Pract Concept2012https://conductscience.org/library/papers/23785613PubMed
8199108Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases.Br J Ophthalmol1994https://conductscience.org/library/papers/8199108PubMed
7149819A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia.Ann Surg1982https://conductscience.org/library/papers/7149819PubMed
6822677Prognostic value of tumour thickness in cutaneous malignant melanoma.J Clin Pathol1983https://conductscience.org/library/papers/6822677PubMed
6508408Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment.Ann Surg1984https://conductscience.org/library/papers/6508408PubMed
6508406The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma.Ann Surg1984https://conductscience.org/library/papers/6508406PubMed
6476888Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (less than or equal to 1.5 mm) melanoma.Arch Dermatol Res1984https://conductscience.org/library/papers/6476888PubMed
6416500The incidental malignant melanoma.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6416500PubMed
6415909Histological type and biological behavior of primary cutaneous malignant melanoma. 1. An analysis of 1916 cases.Virchows Arch A Pathol Anat Histopathol1983https://conductscience.org/library/papers/6415909PubMed
6412848The incidental malignant melanoma.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6412848PubMed
6398936The ultrastructure of conjunctival melanocytic tumors.Trans Am Ophthalmol Soc1984https://conductscience.org/library/papers/6398936PubMed
4015217Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator.Ann Surg1985https://conductscience.org/library/papers/4015217PubMed
3977452Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression.Ann Surg1985https://conductscience.org/library/papers/3977452PubMed
3977262Biopsy procedures, primary wide excisional surgery and long term prognosis in primary clinical stage I invasive cutaneous malignant melanoma.Ann R Coll Surg Engl1985https://conductscience.org/library/papers/3977262PubMed
3923697Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. A multivariate regression analysis.Virchows Arch A Pathol Anat Histopathol1985https://conductscience.org/library/papers/3923697PubMed
3460702
Phase II study of vaccinia melanoma cell lysates (VMCL) as adjuvant to surgical treatment of stage II melanoma. II. Effects on cell mediated cytotoxicity and leucocyte dependent antibody activity: immunological effects of VMCL in melanoma patients.
Cancer Immunol Immunother1986https://conductscience.org/library/papers/3460702PubMed
3355269Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma.Ann Surg1988https://conductscience.org/library/papers/3355269PubMed
2815804Hyperthermic perfusion with chemotherapy for melanoma of the extremities.World J Surg1989https://conductscience.org/library/papers/2815804PubMed

See all 22 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/488922

GET https://conductscience.org/api/papers/v1/488922/cited_by?page=2